Business Context and Reporting Period
This Form 8-K Current Report was filed by DaVita Inc. on June 19, 2003. The report discloses a material event involving the company's wholly-owned subsidiary, Renal Treatment Centers, Inc. ("RTC").
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, margin, or liquidity figures. The primary financial disclosure relates to the debt instrument known as the 5 5/8% Convertible Subordinated Notes due 2006.
Material Changes
RTC has issued a notice of redemption for all of its outstanding 5 5/8% Convertible Subordinated Notes due 2006. This action represents a significant change in the company's capital structure and debt obligations.
Guidance, Outlook, and Risks
The filing incorporates by reference a press release (Exhibit 99.1) detailing the redemption. No specific forward-looking guidance, management commentary on future performance, or new risk factors are explicitly detailed within the text of this 8-K form, other than the execution of the debt redemption.
Investor Verification Checklist
- Verify the specific redemption price and payment date for the 5 5/8% Convertible Subordinated Notes due 2006 in the attached press release (Exhibit 99.1).
- Confirm the total principal amount of the Notes being redeemed to assess the immediate cash outflow impact.
- Review the subsidiary's (RTC) financial statements to understand the source of funds used for the redemption.
- Check for any conversion activity by noteholders prior to the redemption notice.